As of 2025-11-08, the Intrinsic Value of Immunic Inc (IMUX) is -5.16 USD. This IMUX valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.72 USD, the upside of Immunic Inc is -818.27%.
Based on its market price of 0.72 USD and our intrinsic valuation, Immunic Inc (IMUX) is overvalued by 818.27%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -5.16 - -5.16 | -5.16 | -818.27% |
| P/E | (27.05) - (3.28) | (18.27) | -2642.7% |
| DDM - Stable | (6.31) - (25.56) | (15.94) | -2317.5% |
| DDM - Multi | (0.69) - (2.27) | (1.07) | -249.0% |
| Market Cap (mil) | 70.89 |
| Beta | 0.85 |
| Outstanding shares (mil) | 98.65 |
| Enterprise Value (mil) | 15.58 |
| Market risk premium | 4.60% |
| Cost of Equity | 11.54% |
| Cost of Debt | 5.00% |
| WACC | 7.60% |